Lilly Stock Slips On Mixed Bag Q2 Earnings, Cuts FY21 Sales Outlook For COVID-19 Therapies

Eli Lilly And Co posted Q2 sales of $6.74 billion, beating the consensus of $6.65 billion and an increase of 23% Y/Y,
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.